Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Duodenal Neoplasms 1Colorectal Neoplasms 1Barrett Esophagus 1Attenuated familial adenomatous polyposis 1Adenomatous Polyposis Coli 1Adenocarcinoma Of Esophagus 1

Interventions

Specimen Handling 4Endoscopy 3Biopsy 3Itraconazole 2Endoscopy, Digestive System 2Diagnostic Imaging 2plecanatide 1obeticholic acid 1linaclotide 1Spectrum Analysis 1Sampling Studies 1Risk Assessment 1Radiofrequency Ablation 1Mass Screening 1Hematologic Tests 1Gastroscopy 1Endoscopic Mucosal Resection 1Cryosurgery 1Cetuximab 1Breath Tests 1Bevacizumab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Barrett Esophagus × obeticholic acid × 1 year × Clear all
NCT04939051 2026-05-13

Obeticholic Acid for Prevention in Barrett's Esophagus

National Cancer Institute (NCI)

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡